These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

943 related articles for article (PubMed ID: 28320347)

  • 1. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study.
    Mukose AD; Bastiaens H; Makumbi F; Buregyeya E; Naigino R; Musinguzi J; Van Geertruyden JP; Wanyenze RK
    PLoS One; 2021; 16(5):e0251181. PubMed ID: 33951109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
    Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
    AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
    PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'I wanted to safeguard the baby': a qualitative study to understand the experiences of Option B+ for pregnant women and the potential implications for 'test-and-treat' in four sub-Saharan African settings.
    McLean E; Renju J; Wamoyi J; Bukenya D; Ddaaki W; Church K; Zaba B; Wringe A
    Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV status disclosure and associated outcomes among pregnant women enrolled in antiretroviral therapy in Uganda: a mixed methods study.
    Naigino R; Makumbi F; Mukose A; Buregyeya E; Arinaitwe J; Musinguzi J; Wanyenze RK
    Reprod Health; 2017 Aug; 14(1):107. PubMed ID: 28854944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and commonly used countermeasures in the implementation of lifelong antiretroviral therapy for PMTCT in Central Uganda: Health providers' perspective.
    Mukose AD; Bastiaens H; Makumbi F; Buregyeya E; Naigino R; Musinguzi J; Van Geertruyden JP; Wanyenze RK
    PLoS One; 2023; 18(1):e0280893. PubMed ID: 36662894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda.
    Alhassan Y; Twimukye A; Malaba T; Myer L; Waitt C; Lamorde M; Colbers A; Reynolds H; Khoo S; Taegtmeyer M
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):566. PubMed ID: 35840939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the acceptability of Option B plus among HIV-positive Nigerian women engaged and not engaged in the prevention of mother-to-child transmission of HIV cascade: a qualitative study.
    Erekaha SC; Cornelius LJ; Bessaha ML; Ibrahim A; Adeyemo GD; Fadare M; Charurat M; Ezeanolue EE; Sam-Agudu NA
    SAHARA J; 2018 Dec; 15(1):128-137. PubMed ID: 30253709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa.
    Adeniyi OV; Ajayi AI; Ter Goon D; Owolabi EO; Eboh A; Lambert J
    BMC Infect Dis; 2018 Apr; 18(1):175. PubMed ID: 29653510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying barriers to ART initiation and adherence: An exploratory qualitative study on PMTCT in Zambia.
    Kanguya T; Koyuncu A; Sharma A; Kusanathan T; Mubanga M; Chi BH; Vinikoor MJ; Mubiana-Mbewe M
    PLoS One; 2022; 17(1):e0262392. PubMed ID: 35025923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Mother-to-Child Transmission of HIV in Option B+ Era: Uptake and Adherence During Pregnancy in Western Uganda.
    Schnack A; Rempis E; Decker S; Braun V; Rubaihayo J; Busingye P; Tumwesigye NM; Harms G; Theuring S
    AIDS Patient Care STDS; 2016 Mar; 30(3):110-8. PubMed ID: 27308804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing retention of HIV positive pregnant and breastfeeding mothers on option-b plus by upgrading and providing full time HIV services at a lower health facility in rural Uganda.
    Masereka EM; Ngabirano TD; Osingada CP; Wiltshire CS; Castelnuovo B; Kiragga AN
    BMC Public Health; 2019 Jul; 19(1):950. PubMed ID: 31307455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women - a qualitative study.
    Katirayi L; Chouraya C; Kudiabor K; Mahdi MA; Kieffer MP; Moland KM; Tylleskar T
    BMC Public Health; 2016 Oct; 16(1):1119. PubMed ID: 27776495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study.
    Kiwanuka G; Kiwanuka N; Muneza F; Nabirye J; Oporia F; Odikro MA; Castelnuovo B; Wanyenze RK
    BMC Infect Dis; 2018 Oct; 18(1):533. PubMed ID: 30355356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Disclosure Among Pregnant Women Initiating ART in Cape Town, South Africa: Qualitative Perspectives During the Pregnancy and Postpartum Periods.
    Watt MH; Knippler ET; Knettel BA; Sikkema KJ; Ciya N; Myer L; Joska JA
    AIDS Behav; 2018 Dec; 22(12):3945-3956. PubMed ID: 30196332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.